Cargando…

A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions

INTRODUCTION: To integrate and execute a proper preventive plan and reduce the risk of non-communicable diseases (NCDs), policy makers need to have access to both reliable data and a unique definition of metabolic syndrome (MetS). This study was conducted on the data collected by cross-sectional stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabatabaei-Malazy, Ozra, Saeedi Moghaddam, Sahar, Rezaei, Nazila, Sheidaei, Ali, Hajipour, Mohammad Javad, Mahmoudi, Negar, Mahmoudi, Zohreh, Dilmaghani-Marand, Arezou, Rezaee, Kamyar, Sabooni, Mahdi, Razi, Farideh, Kompani, Farzad, Delavari, Alireza, Larijani, Bagher, Farzadfar, Farshad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928520/
https://www.ncbi.nlm.nih.gov/pubmed/33657130
http://dx.doi.org/10.1371/journal.pone.0241926
_version_ 1783659874723299328
author Tabatabaei-Malazy, Ozra
Saeedi Moghaddam, Sahar
Rezaei, Nazila
Sheidaei, Ali
Hajipour, Mohammad Javad
Mahmoudi, Negar
Mahmoudi, Zohreh
Dilmaghani-Marand, Arezou
Rezaee, Kamyar
Sabooni, Mahdi
Razi, Farideh
Kompani, Farzad
Delavari, Alireza
Larijani, Bagher
Farzadfar, Farshad
author_facet Tabatabaei-Malazy, Ozra
Saeedi Moghaddam, Sahar
Rezaei, Nazila
Sheidaei, Ali
Hajipour, Mohammad Javad
Mahmoudi, Negar
Mahmoudi, Zohreh
Dilmaghani-Marand, Arezou
Rezaee, Kamyar
Sabooni, Mahdi
Razi, Farideh
Kompani, Farzad
Delavari, Alireza
Larijani, Bagher
Farzadfar, Farshad
author_sort Tabatabaei-Malazy, Ozra
collection PubMed
description INTRODUCTION: To integrate and execute a proper preventive plan and reduce the risk of non-communicable diseases (NCDs), policy makers need to have access to both reliable data and a unique definition of metabolic syndrome (MetS). This study was conducted on the data collected by cross-sectional studies of WHO’s STEPwise approach to surveillance of NCD risk factors (STEPs) to estimate the national and sub-national prevalence rates of MetS in Iran in 2016. MATERIALS AND METHODS: The prevalence of MetS was estimated among 18,414 individuals aged ≥25 years living in urban and rural areas of Iran using various definition criteria; National Cholesterol Education Program Adult Treatment Panel III 2004 (ATP III), International Diabetes Federation (IDF), American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), Joint Interim Statement (JIS). Regional IDF (RIDF) and JIS (RJIS) were defined using ethnicity-specific values of waist circumference for the country. RESULTS: National prevalence rate of MetS based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS criteria were 38.3% (95% CI 37.4–39.1), 43.5% (42.7–44.4), 40.9% (40.1–41.8), 47.6% (46.8–48.5), 32.0% (31.2–32.9), and 40.8% (40.0–41.7), respectively. The prevalence was higher among females, in urban residents, and those aged 65–69 years. MetS was expected to affect about 18.7, 21.3, 20.0, 23.3, 15.7, and 20.0 million Iranians, respectively, based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS. The two most common components noted in this population were reduced high-density lipoprotein cholesterol (HDL-C) levels and central obesity. CONCLUSION: High prevalence rate of MetS among Iranian adults is alarming, especially among females, urban residents, and the elderly. The JIS definition criteria is more appropriate to determine higher number of Iranians at risk of NCDs. Proper management and prevention of MetS is required to adopt multiple national plans including lifestyle modifications, medical interventions, and public education on NCDs risk factors.
format Online
Article
Text
id pubmed-7928520
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-79285202021-03-10 A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions Tabatabaei-Malazy, Ozra Saeedi Moghaddam, Sahar Rezaei, Nazila Sheidaei, Ali Hajipour, Mohammad Javad Mahmoudi, Negar Mahmoudi, Zohreh Dilmaghani-Marand, Arezou Rezaee, Kamyar Sabooni, Mahdi Razi, Farideh Kompani, Farzad Delavari, Alireza Larijani, Bagher Farzadfar, Farshad PLoS One Research Article INTRODUCTION: To integrate and execute a proper preventive plan and reduce the risk of non-communicable diseases (NCDs), policy makers need to have access to both reliable data and a unique definition of metabolic syndrome (MetS). This study was conducted on the data collected by cross-sectional studies of WHO’s STEPwise approach to surveillance of NCD risk factors (STEPs) to estimate the national and sub-national prevalence rates of MetS in Iran in 2016. MATERIALS AND METHODS: The prevalence of MetS was estimated among 18,414 individuals aged ≥25 years living in urban and rural areas of Iran using various definition criteria; National Cholesterol Education Program Adult Treatment Panel III 2004 (ATP III), International Diabetes Federation (IDF), American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), Joint Interim Statement (JIS). Regional IDF (RIDF) and JIS (RJIS) were defined using ethnicity-specific values of waist circumference for the country. RESULTS: National prevalence rate of MetS based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS criteria were 38.3% (95% CI 37.4–39.1), 43.5% (42.7–44.4), 40.9% (40.1–41.8), 47.6% (46.8–48.5), 32.0% (31.2–32.9), and 40.8% (40.0–41.7), respectively. The prevalence was higher among females, in urban residents, and those aged 65–69 years. MetS was expected to affect about 18.7, 21.3, 20.0, 23.3, 15.7, and 20.0 million Iranians, respectively, based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS. The two most common components noted in this population were reduced high-density lipoprotein cholesterol (HDL-C) levels and central obesity. CONCLUSION: High prevalence rate of MetS among Iranian adults is alarming, especially among females, urban residents, and the elderly. The JIS definition criteria is more appropriate to determine higher number of Iranians at risk of NCDs. Proper management and prevention of MetS is required to adopt multiple national plans including lifestyle modifications, medical interventions, and public education on NCDs risk factors. Public Library of Science 2021-03-03 /pmc/articles/PMC7928520/ /pubmed/33657130 http://dx.doi.org/10.1371/journal.pone.0241926 Text en © 2021 Tabatabaei-Malazy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tabatabaei-Malazy, Ozra
Saeedi Moghaddam, Sahar
Rezaei, Nazila
Sheidaei, Ali
Hajipour, Mohammad Javad
Mahmoudi, Negar
Mahmoudi, Zohreh
Dilmaghani-Marand, Arezou
Rezaee, Kamyar
Sabooni, Mahdi
Razi, Farideh
Kompani, Farzad
Delavari, Alireza
Larijani, Bagher
Farzadfar, Farshad
A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
title A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
title_full A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
title_fullStr A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
title_full_unstemmed A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
title_short A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
title_sort nationwide study of metabolic syndrome prevalence in iran; a comparative analysis of six definitions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928520/
https://www.ncbi.nlm.nih.gov/pubmed/33657130
http://dx.doi.org/10.1371/journal.pone.0241926
work_keys_str_mv AT tabatabaeimalazyozra anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT saeedimoghaddamsahar anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT rezaeinazila anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT sheidaeiali anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT hajipourmohammadjavad anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT mahmoudinegar anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT mahmoudizohreh anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT dilmaghanimarandarezou anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT rezaeekamyar anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT saboonimahdi anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT razifarideh anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT kompanifarzad anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT delavarialireza anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT larijanibagher anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT farzadfarfarshad anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT tabatabaeimalazyozra nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT saeedimoghaddamsahar nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT rezaeinazila nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT sheidaeiali nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT hajipourmohammadjavad nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT mahmoudinegar nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT mahmoudizohreh nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT dilmaghanimarandarezou nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT rezaeekamyar nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT saboonimahdi nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT razifarideh nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT kompanifarzad nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT delavarialireza nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT larijanibagher nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions
AT farzadfarfarshad nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions